Starting with four carefully curated product-based challenges, iPitch aims to draw out fresh ideas and prospective business partnerships. The first four public challenges opened on 23 September and close on 4 November 2019. The challenges broadly cover:
1. Sore Throat Challenge
2. Vaporising Delivery System Challenge
3. Wound and Scar Challenge; and
4. A Wild Card challenge!
iPitch is open to anyone with a great idea for a product or device that has the potential for commercialisation according to the criteria set out for each challenge.
iNova’s Executive Director and Head of Innovation, Filomena Maiese, believes iPitch represents a fantastic opportunity for innovators and iNova alike:
“We know there are great Consumer Health product innovations out there that haven’t yet been commercialised, and product developers who may not have the expertise or resources to bring their innovations to market. We are looking for efficacious, evidence-based products with innovative formulations and novel formats,” Ms Maiese said. “We want to partner with innovators to deliver next-generation solutions to delight our consumers.”
CEO, Dan Spira, believes iNova offers an attractive platform for prospective business partners:
“iNova has a diverse stable of market-leading products, a trusted reputation among consumers and healthcare professionals, a unique multi-national footprint, a well-established operating platform and broad distribution network across 20 countries in Asia, Africa and ANZ. We have a strong track record of acquiring, launching and building Consumer Health products,” said Mr Spira. “Those factors make us a partner of choice for product owners and licensors globally.”
Written submissions will initially be assessed by an internal panel of judges. Select submissions for each challenge will then be short-listed for the iPitch Slam, where applicants will have the opportunity deliver their pitch in person.
Further details on the initial four iPitch challenges can be found at www.inovapharma.com/innovation.
